Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion type Assertion NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_head.
- NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion description "[Overexpression of p53, normally secondary to gene mutation, in invasive uroepithelial neoplasms (transitional cell carcinoma) and a high percentage of transitional cell carcinoma in situ (CIS) has been described; however, the role of p53 before and after bacillus Calmette-Gu�rin (BCG) treatment of CIS needs to be defined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_provenance.
- NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion evidence source_evidence_literature NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_provenance.
- NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion SIO_000772 9111623 NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_provenance.
- NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion wasDerivedFrom befree-20150227 NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_provenance.
- NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_assertion wasGeneratedBy ECO_0000203 NP752805.RA3DujIHn7l9-aJ7Pq_UAjzly2o8r0YkK77gemX738GRE130_provenance.